Jacobi Medical Center
Bronx, New York, United States
Hospital in the Bronx, New York
1400 Pelham Pkwy S, Bronx, NY 10461
About Jacobi Medical Center
Jacobi Medical Center is a municipal hospital operated by NYC Health + Hospitals in affiliation with the Albert Einstein College of Medicine. The facility is located in the Morris Park neighborhood of the Bronx, New York City.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
65
Gilead Sciences
14
Albert Einstein College of Medicine
10
New York City Health and Hospitals Corporation
10
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
9
North Bronx Healthcare Network
6
Duke University
3
Global Blood Therapeutics
3
Harvard School of Public Health (HSPH)
3
Jacobi Medical Center
3
MedImmune LLC
3
Clinical Trials at Jacobi Medical Center
During the past decade, Jacobi Medical Center conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 49 clinical trials were completed, i.e. on
average, 73.1% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 25 clinical trials were completed. i.e. 89.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1999-09-01
Completed
2,000
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
1996-02-01
Completed
100
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
Completed
750
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Completed
660
A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP
1990-05-01
Completed
482
A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
1990-08-01
Completed
315
Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
Completed
120
An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies
2004-07-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Jacobi Medical Center" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 65 trials, followed by "Gilead Sciences" with 14 trials
sponsored, "Albert Einstein College of Medicine" with 10 trials sponsored, "New York City Health and Hospitals Corporation" with 10 trials sponsored and "International Maternal Pediatric Adolescent AIDS Clinical Trials Group"
with 10 trials sponsored. Other sponsors include 84 different institutions and
companies that sponsored additional 69 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jacobi Medical Center"
#1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 34 trials as a collaborator, "Jacobi Medical Center" with 16 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 12 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 8 trials as a collaborator. Other collaborators include 130 different institutions and companies that were
collaborators in the rest 95 trials.
Clinical Trials Conditions at Jacobi Medical Center
According to Clinical.Site data, the most researched conditions in "Jacobi Medical Center" are
"HIV Infections" (78 trials), "HIV" (12 trials), "COVID-19" (8 trials), "Sickle Cell Disease" (8 trials) and "HIV-1 Infection" (7 trials). Many other conditions were trialed in "Jacobi Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Jacobi Medical Center
Most popular intervention types in "Jacobi Medical Center" are "Drug" (122 trials), "Behavioral" (19 trials), "Biological" (19 trials), "Other" (16 trials) and "Device" (12 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (26 trials), "Zidovudine" (12 trials), "Nevirapine" (8 trials), "Didanosine" (7 trials) and "Ritonavir" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Jacobi Medical Center
The vast majority of trials in "Jacobi Medical Center" are
178 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Jacobi Medical Center
Currently, there are NaN active trials in "Jacobi Medical Center".
undefined are not yet recruiting,
21 are recruiting,
8 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 142 completed trials in Jacobi Medical Center,
3 suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Jacobi Medical Center, 26 "Phase 1"
clinical trials were conducted, 59 "Phase 2" clinical
trials and 49 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 38 trials that are defined as “Not Applicable".